male
femal
blooddonor
serumbilirubin
data
skew
women
bilirubin
z
mgdl
men
bilirubin
mgdl
claim
constitut
second
minor
popul
owen
evan
suggest
gilbert
syndrom
popul
would
disord
found
two
distinct
linear
section
data
plot
normalprob
distinct
logprob
paper
data
plot
normalprob
paper
yield
smooth
logarithm
curv
evid
bimod
differ
could
due
sampl
error
earlier
studi
upper
end
owen
evan
distribut
contain
data
point
fact
data
accommod
singl
lognorm
distribut
thu
weaken
case
bimod
men
bilirubin
recal
usual
criteria
gilbert
syndromei
serumbilirubin
rose
bilirubin
mainli
unconjug
gross
haemolysi
exclud
minor
haemolysi
demonstr
patient
gilbert
syndrom
enough
account
surpris
repeat
bilirubin
slightli
differ
first
one
patient
rais
bilirubin
concentr
vari
patient
fast
second
examin
gilbert
syndrom
diseas
mere
extrem
express
normal
low
uridinediphosph
glucuronyl
transferas
alter
bilirubin
slightli
reduc
redbloodcel
even
genet
mean
repres
diseas
state
one
would
expect
find
differ
factor
control
bilirubin
concentr
group
peopl
high
bilirubin
compar
lower
bilirubin
feasibl
measur
larg
normal
popul
factor
could
also
expect
skew
distribut
frequenc
symptom
patient
gilbert
diseas
probabl
reflect
way
diagnosedi
blood
test
done
investig
vagu
lassitud
discomfort
recal
patient
symptom
suggest
constitut
hyperbilirubinaemia
use
prefer
gilbert
diseas
patient
reassur
condit
produc
symptom
unnecessari
investig
order
futur
nonassoci
ill
bilirubin
may
found
increas
certainli
treatment
phenobarbiton
lower
bilirubin
diminish
vagu
symptom
seem
misplac
failur
recognis
distribut
bilirubin
concentr
skew
subsequ
misappl
gaussian
statist
techniqu
yield
misleadingli
low
upper
limit
normal
upper
limit
micro
moll
mgdl
seem
low
percentil
popul
mgdl
femal
mgdl
male
valu
realist
defin
upper
limit
normal
even
strict
criteria
screen
men
abnorm
bilirubin
concentr
almost
hepatocellular
diseas
would
past
diagnos
gilbert
diseas
request
reprint
address
r
medic
centr
pentonvil
road
london
hospit
region
viru
laboratori
citi
hospit
edinburgh
summari
urin
eight
normal
control
influenzalik
ill
develop
contain
high
concentr
fibrindegrad
product
fdp
igg
studi
carri
influenza
preval
commun
howev
wide
rang
serolog
investig
reveal
evid
influenza
virus
infect
may
caus
virus
produc
upperrespiratorytract
infect
readili
diagnos
serolog
urinari
fibrindegrad
product
wellknown
marker
glomerulonephrit
activ
viral
antigen
may
induc
immunecomplex
glomerulonephr
control
influenzalik
diseas
develop
larger
normal
popul
investig
viru
epidem
introduct
immunolog
basi
glomerulonephr
well
establish
immunofluoresc
studi
shown
immunoglobulin
glomeruli
patient
glomerulonephr
immunoglobulin
produc
respons
antigen
natur
antigen
often
obscur
demonstr
difficult
howev
numer
bacteri
antigen
especi
streptococci
may
caus
glomerular
damag
immunolog
mechan
chronic
viral
infect
anim
lymphocyt
choriomening
agent
aleutian
diseas
mink
coxsacki
adenoviru
result
immunecomplex
nephriti
man
role
virus
aetiolog
glomerulonephr
studi
chiefli
case
renal
diseas
develop
viral
ill
caus
echoviru
coxsacki
varicella
rais
titr
antiepsteinbarr
demonstr
patient
system
lupu
erythematosu
glomerulonephr
parainfluenza
antibodi
titr
rais
patient
immunecomplex
intravascular
coagul
renal
involv
report
patient
influenzaa
viru
infect
case
goodpastur
syndrom
viru
infect
urin
fibrindegrad
product
accur
marker
activ
glomerulonephrit
process
present
studi
high
concentr
urin
fibrindegrad
product
immunoglobulin
suggest
immunolog
process
consist
subclin
attack
glomerulonephr
occur
epidem
influenzalik
diseas
sixteen
normal
healthi
adult
volunt
agre
take
part
investig
defin
normal
concentr
urin
fibrindegrad
product
fdp
laboratori
ml
urin
collect
daili
earli
morn
month
dialys
tapwat
concentr
polyethylen
glycol
deg
c
overnight
store
deg
c
assay
tan
redcel
haemagglutinationinhibit
use
follow
modif
immunoassay
perform
microtitr
system
cook
engin
co
reagent
fibrinogen
standard
sensitis
cell
batch
three
concentr
human
fibrinogen
kabi
pharmaceut
ltd
lot
includ
assay
concentr
clottabl
protein
standard
estim
method
ratnoff
menzi
mean
sensit
assay
calcul
valu
concentrationofantisera
burrough
wellcomelot
k
antigenantibodi
incub
period
h
deg
c
incub
period
addit
sensitis
cell
h
overnight
deg
c
human
glutaraldehydefix
fibrinogen
gml
kabi
pharmaceut
ltd
lot
sensitis
cell
use
plate
read
two
observ
agre
within
half
well
igg
igm
measur
mancini
techniqu
limit
amount
urin
avail
analysi
urin
examin
protein
content
blood
labstix
investig
clinic
evid
influenzalik
syndrom
acut
upperrespiratorytract
symptom
cough
sore
throat
runni
nose
gener
malais
arthralgia
develop
eight
control
lymphadenopathi
develop
one
three
absent
work
day
studi
epidem
influenza
commun
caus
parainfluenza
b
virus
blood
taken
viru
studi
attack
one
month
later
serum
investig
antibodi
wide
rang
virus
complementfix
antibodi
titr
follow
antigen
determin
influenza
b
parainfluenza
type
adenoviru
chlamydia
group
b
coxiella
burneti
mycoplasma
pneumonic
respiratori
syncyti
viru
antibodi
coxsacki
virus
measur
metabol
inhibit
test
serum
test
heterophil
paul
bunnel
antibodi
streptolysin
antibodi
influenzalik
ill
blood
also
taken
measur
serumpdp
bloodurea
serumcreatinin
platelet
reticulocytecount
haptoglobulin
prothrombin
index
thrombintim
bloodfilm
studi
fragment
cell
burr
cell
detect
evid
intravascular
coagul
urinari
fdp
igg
concentr
shown
two
control
influenzalik
ill
fig
mean
urin
fdp
concentr
ill
eight
control
sn
plusmn
significantli
higher
mean
concentr
control
ill
proteinuria
found
two
control
mgdl
method
use
measur
urinari
protein
poor
insuffici
urin
carri
detail
protein
estim
biuret
method
blood
associ
menstruat
detect
microscopi
two
consecut
urin
sampl
one
woman
ill
blood
urea
creatinin
rais
control
time
serum
antibodi
titr
antigen
test
rais
eight
control
throat
nasal
swab
taken
paul
bunnel
test
heterophil
antibodi
neg
eight
case
routin
bacteriolog
cultur
neg
antistreptolysin
titr
rais
eight
control
result
haematolog
investig
dissemin
intravascular
coagul
within
normal
limit
urin
fdp
complement
igg
rais
eight
sixteen
adult
control
studi
eight
urinari
chang
associ
influenzalik
ill
chang
urin
eight
control
remain
well
throughout
studi
possibl
viru
respons
influenzalik
ill
investig
infect
occur
begin
april
influenzaa
infect
preval
area
howev
eight
control
affect
serolog
evid
influenzaa
infect
infect
wide
rang
virus
howev
infect
may
caus
virus
mdash
eg
rhinoviru
echoviru
coronaviru
known
caus
upper
respiratori
infectionwhich
readili
diagnos
serolog
although
laboratori
confirm
viral
infect
clinic
ill
upperrespiratorytract
symptom
gener
malais
fever
arthralgia
compat
infect
excret
fdp
complement
igg
urin
associ
immun
complex
consist
viral
antigen
antibodi
may
respons
glomerular
nephrit
process
eight
control
urinari
fibrindegrad
product
igg
complement
rais
man
laboratori
anim
immunecomplex
diseas
due
deposit
viral
antigenantibodi
complex
glomeruli
may
import
sinc
coxsackieb
australia
antigen
observ
glomeruli
patient
nephriti
other
use
explant
cultur
attempt
isol
virus
directli
renal
tissu
obtain
either
necropsi
diagnost
cytomegaloviru
adenoviru
measl
varicella
coxsacki
viru
bl
isol
infant
kidney
obtain
necropsi
kidney
older
particl
characterist
coronavirus
seen
kidney
patient
endem
balkan
ctype
rna
virus
implic
aetiolog
system
lupu
kidney
patient
lupu
nephropathi
found
contain
antigen
relat
ctype
viru
human
cell
viru
urin
fibrindegrad
product
complement
immunoglobulin
protein
excret
measur
prospect
detail
viru
studi
carri
epidem
influenza
viral
infect
larger
normal
popul
request
reprint
address
j
l
depart
medicin
western
gener
hospit
edinburgh
